Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulised Abelcet for IPA Prophylaxis in Pediatric Leukemia
NCT01615809Phase 2Completed
- Sponsor
- Fundació Sant Joan de Déu
- Start
- Oct 2011
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amphotericin b in Invasive Pulmonary Aspergillosis (IPA), sponsored by Fundació Sant Joan de Déu. Started Oct 2011; status: completed.
02
Drugs
amphotericin b
03
Conditions
Invasive Pulmonary Aspergillosis (IPA)
Beyond the preview
Go deeper on NCT01615809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01615809.